Clinical Trial

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 30, 2023 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Locally advanced cervical cancer (stage IB3, IIA2) patients with postoperative risk factors need better treatment. We initiated a clinical study to explore the effectiveness of adjuvant chemoradiotherapy followed by Zimberelimab for these patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-09.
Trial Details
NCT Number NCT06128460
Lead Sponsor Obstetrics & Gynecology Hospital of Fudan University
Conditions Cervical Cancer
Enrollment 24 participants
Start Date 2023-12-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2023-11-30